首頁 > 市場調查報告書 > 醫療設備

導管醫學影像診斷 CT/MRI/X光分子呈像/呈影劑

市場調查報告書

商品編碼

1071419

血管造影術設備:市場預測(2022年～2027年)

Angiography Equipment Market - Forecasts from 2022 to 2027

出版日期: 2022年03月01日 | 出版商:

Knowledge Sourcing Intelligence | 英文 131 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

全球血管造影術設備的市場規模在2020年估算為125億1,300萬美金，在預測期間內預計將以7.92％的年複合成長率擴大，2027年成為213億3,400萬美元。市場成長的主要因素有高患病率，以及全球癌症和心血管疾病發病率的增加等。

不斷增長的老年人口和世界肥胖人口導致需要血管造影的疾病激增。各個發達地區對產品批准的有利政府法規預計將推動全球市場增長。此外，對微創手術的偏好不斷變化，增加了對血管造影系統的需求。血管造影設備創新的進步預計將有助於市場增長，因為它們改善了醫療流程。然而，與採購和使用先進血管造影設備相關的高成本是全球市場增長的主要障礙。

本報告提供血管造影術設備的世界市場調查，提供市場規模和預測，市場促進因素及課題，市場趨勢，各市場區隔的市場分析，競爭情形，主要企業的簡介等系統性資訊。

The high prevalence, coupled with the increasing incidence of cancer and cardiovascular diseases around the world, is one of the major factors anticipated to drive the growth of the angiography equipment market during the forecast period. The rise in the geriatric population and an increase in the growing number of obese people around the world are leading to a surge in diseases that require angiography. Furthermore, favourable government regulations for the approval of the product in the various developed regions are also expected to fuel the growth of the global market. There is also a growing demand for angiography systems due to a shift in preference towards minimally invasive surgeries. Moreover, growing innovations in angiography equipment are improving the medical process and, hence, are anticipated to contribute to the market growth. However, high costs associated with the procurement and use of technologically advanced angiography equipment are a major factor likely to hamper the growth of the global market.

The recent outbreak of the novel coronavirus disease has a negative impact on the angiography equipment market. The pandemic shifted the major focus of the healthcare system towards COVID-19, and as part of the COVID-19 restrictions, a large number of procedures and surgeries had to be cancelled in many parts of the world, which led to a decline in the angiography equipment market in 2020. However, as the restrictions are being eased in most parts of the world, the market is anticipated to recover and continue at its normal pace from the year 2022 onwards.

The increasing prevalence of cardiovascular diseases

The world is witnessing a surge in the number of cases of cardiovascular diseases over the years, which is leading to an increased demand for angiography equipment and is projected to boost the market growth during the forecast period. A paper in the Journal of the American College of Cardiology stated in December 2020 that there were 270 million cases of cardiovascular diseases in 1990, which nearly doubled to 523 million in 2019. It also states that the number of people who died from cardiovascular disease increased from 12.1 million in 1990 to 18.6 million in 2019. The American Heart Association (AHA) predicts that 45% of the population of the United States will have at least one heart-related problem. It also estimates that the costs related to cardiovascular diseases will increase by 100% between 2016 and 2035. According to WHO, cardiovascular disease has the highest share in the list of leading causes of death. The organisation states that cardiovascular diseases caused 17.9 million deaths in 2019 around the world and represented 32% of all deaths worldwide. Premature deaths are also increasing with the growing prevalence of heart diseases, with 38% of all the 17 million premature deaths due to non-communicable diseases caused by CVDs in 2019. The growing trend of CVDs is projected to continue in the coming years as well and is anticipated to drive the market growth of angiography equipment.

Increase in innovation

The rising innovations in the market and the launch of advanced angiography equipment by the market players are widening the scope of angiography equipment and are anticipated to propel the growth of angiography equipment during the assessment period. The medical device company Kinepict Health has developed Kinepict Medical Imaging Tool (KMIT) software which uses the Digital Variance Angiography (DVA) technology and provides superior image quality compared to the conventionally-used technologies. The FDA has given clearance for it in March 2020, which has allowed it to be launched in the U.S. market. Furthermore, GE Healthcare has introduced the Allia IGS 7 angiography system at the Radiological Society of North America (RSNA) 2020 virtual meeting. The system makes use of artificial intelligence and allows better use of rotational angiography. Several other innovative products are being launched by various companies, leading to improvements in the angiography process and are anticipated to spur the growth of angiography equipment during the forecast period.

North America held a significant market share.

Geographically, the North American region is anticipated to hold a significant market share owing to the presence of a large number of market leaders, coupled with a high prevalence of cardiovascular diseases. Also, the presence of an advanced healthcare system allows a larger adoption of new and advanced angiography equipment. The Asia Pacific region is anticipated to witness substantial growth due to the rising number of cases of CVDs, coupled with increased investments in the healthcare sector in the region, which will lead to the availability of requisite healthcare facilities.

Market Segmentation

By Technology

X-Ray Angiography

Computed Tomography Angiography

Magnetic Resonance Angiography

By Procedure

Coronary

Endovascular

Neurovascular

By Application

Diagnostic

Therapeutic

By End-User

Hospitals and Clinics

Research Institutes

Diagnostic Centers

By Geography

North America

USA
Canada
Mexico

South America

Brazil
Argentina
Others

Europe

Germany
France
UK
Spain
Others

Middle East and Africa

Saudi Arabia
UAE
Others

Asia Pacific

China
India
Japan
South Korea
Taiwan
Thailand
Indonesia
Others

1. Introduction

1.1. Market Definition
1.2. Market Segmentation

2. Research Methodology

2.1. Research Data
2.2. Assumptions

3. Executive Summary

3.1. Research Highlights

4. Market Dynamics

4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
- 4.3.1. Bargaining Power of End-Users
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. Angiography Equipment Market Analysis, by Technology

5.1. Introduction
5.2. X-Ray Angiography
5.3. Computed Tomography Angiography
5.4. Magnetic Resonance Angiography

6. Angiography Equipment Market Analysis, by Procedure

6.1. Introduction
6.2. Coronary
6.3. Endovascular
6.4. Neurovascular

7. Angiography Equipment Market Analysis, by Application

7.1. Introduction
7.2. Diagnostic
7.3. Therapeutic

8. Angiography Equipment Market Analysis, by End-User

8.1. Introduction
8.2. Hospitals and Clinics
8.3. Research Institutes
8.4. Diagnostic Centers

9. Angiography Equipment Market Analysis, by Geography

9.1. Introduction
9.2. North America
- 9.2.1. USA
- 9.2.2. Canada
- 9.2.3. Mexico
9.3. South America
- 9.3.1. Brazil
- 9.3.2. Argentina
- 9.3.3. Others
9.4. Europe
- 9.4.1. Germany
- 9.4.2. France
- 9.4.3. UK
- 9.4.4. Spain
- 9.4.5. Others
9.5. Middle East and Africa
- 9.5.1. Saudi Arabia
- 9.5.2. UAE
- 9.5.3. Others
9.6. Asia Pacific
- 9.6.1. China
- 9.6.2. India
- 9.6.3. Japan
- 9.6.4. South Korea
- 9.6.5. Taiwan
- 9.6.6. Thailand
- 9.6.7. Indonesia
- 9.6.8. Others